255 related articles for article (PubMed ID: 19098162)
1. Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission.
Sotty F; Damgaard T; Montezinho LP; Mørk A; Olsen CK; Bundgaard C; Husum H
J Pharmacol Exp Ther; 2009 Mar; 328(3):951-62. PubMed ID: 19098162
[TBL] [Abstract][Full Text] [Related]
2. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.
Hansen HH; Ebbesen C; Mathiesen C; Weikop P; Rønn LC; Waroux O; Scuvée-Moreau J; Seutin V; Mikkelsen JD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1006-19. PubMed ID: 16775195
[TBL] [Abstract][Full Text] [Related]
3. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.
Hansen HH; Andreasen JT; Weikop P; Mirza N; Scheel-Krüger J; Mikkelsen JD
Eur J Pharmacol; 2007 Sep; 570(1-3):77-88. PubMed ID: 17628530
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
Jensen MM; Lange SC; Thomsen MS; Hansen HH; Mikkelsen JD
Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):339-42. PubMed ID: 21599837
[TBL] [Abstract][Full Text] [Related]
5. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
Hansen HH; Weikop P; Mikkelsen MD; Rode F; Mikkelsen JD
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):46-51. PubMed ID: 27377794
[TBL] [Abstract][Full Text] [Related]
6. Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
Kristensen LV; Sandager-Nielsen K; Hansen HH
Neurosci Lett; 2011 Jan; 488(2):178-82. PubMed ID: 21087654
[TBL] [Abstract][Full Text] [Related]
7. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
Dost R; Rostock A; Rundfeldt C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538
[TBL] [Abstract][Full Text] [Related]
8. M-channels (Kv7/KCNQ channels) that regulate synaptic integration, excitability, and spike pattern of CA1 pyramidal cells are located in the perisomatic region.
Hu H; Vervaeke K; Storm JF
J Neurosci; 2007 Feb; 27(8):1853-67. PubMed ID: 17314282
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.
Gunthorpe MJ; Large CH; Sankar R
Epilepsia; 2012 Mar; 53(3):412-24. PubMed ID: 22220513
[TBL] [Abstract][Full Text] [Related]
10. KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission.
Piccinin S; Randall AD; Brown JT
J Neurophysiol; 2006 May; 95(5):3105-12. PubMed ID: 16467425
[TBL] [Abstract][Full Text] [Related]
11. Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder.
Rode F; Svalø J; Sheykhzade M; Rønn LC
Eur J Pharmacol; 2010 Jul; 638(1-3):121-7. PubMed ID: 20385123
[TBL] [Abstract][Full Text] [Related]
12. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
Zhang D; Thimmapaya R; Zhang XF; Anderson DJ; Baranowski JL; Scanio M; Perez-Medrano A; Peddi S; Wang Z; Patel JR; DeGoey DA; Gopalakrishnan M; Honore P; Yao BB; Surowy CS
J Neurosci Methods; 2011 Aug; 200(1):54-62. PubMed ID: 21723881
[TBL] [Abstract][Full Text] [Related]
13. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
Tatulian L; Delmas P; Abogadie FC; Brown DA
J Neurosci; 2001 Aug; 21(15):5535-45. PubMed ID: 11466425
[TBL] [Abstract][Full Text] [Related]
14. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
[TBL] [Abstract][Full Text] [Related]
16. Suppression of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain.
Cai J; Fang D; Liu XD; Li S; Ren J; Xing GG
Oncol Rep; 2015 Mar; 33(3):1540-50. PubMed ID: 25592230
[TBL] [Abstract][Full Text] [Related]
17. Effects of M-current modulators on the excitability of immature rat spinal sensory and motor neurones.
Rivera-Arconada I; Lopez-Garcia JA
Eur J Neurosci; 2005 Dec; 22(12):3091-8. PubMed ID: 16367775
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
[TBL] [Abstract][Full Text] [Related]
19. Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels.
Rundfeldt C; Netzer R
Arzneimittelforschung; 2000 Dec; 50(12):1063-70. PubMed ID: 11190770
[TBL] [Abstract][Full Text] [Related]
20. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
